synthesis of eicosanoids, glycerolipids and isoprenoids

23
Synthesis of Eicosanoids, Glycerolipids and Isoprenoids

Upload: lilian-woods

Post on 08-Jan-2018

233 views

Category:

Documents


0 download

DESCRIPTION

Eicosanoids Eicosanoids are important regulatory molecules Referred to as local regulators. Function where they are produced. Two classes: Prostaglandins/thromboxanes, and Leukotrienes Prostaglandins – mediate pains sensitivity, inflammation and swelling Thromboxanes – involved in blood clotting, constriction of arteries Leukotrienes – attract white cells, involved inflammatory diseases (asthma, arthritis, etc..)

TRANSCRIPT

Page 1: Synthesis of Eicosanoids, Glycerolipids and Isoprenoids

Synthesis of Eicosanoids, Glycerolipids and

Isoprenoids

Page 2: Synthesis of Eicosanoids, Glycerolipids and Isoprenoids

Eicosanoids• Eicosanoids are important regulatory

molecules • Referred to as local regulators. Function

where they are produced.• Two classes: Prostaglandins/thromboxanes,

and Leukotrienes• Prostaglandins – mediate pains sensitivity,

inflammation and swelling• Thromboxanes – involved in blood clotting,

constriction of arteries• Leukotrienes – attract white cells, involved

inflammatory diseases (asthma, arthritis, etc..)

Page 3: Synthesis of Eicosanoids, Glycerolipids and Isoprenoids

Eicosanoids

Page 4: Synthesis of Eicosanoids, Glycerolipids and Isoprenoids

Eicosanoid Synthesis• C20 unsaturated

fatty acids (i.e. arachidonic acid (20:4D5,8,11,14) are precursors

• Prostaglandins and Thromboxanes are synthesized by a cyclooxygenase pathway

• Leukotirenes are synthesized by a lipoxygenase pathway

cyclooxygenase

Page 5: Synthesis of Eicosanoids, Glycerolipids and Isoprenoids

• Arachidonic acid present in membrane lipids are released for eicosanoid synthesis in the cell interior by phospholipase A2

Page 6: Synthesis of Eicosanoids, Glycerolipids and Isoprenoids

Cyclooxygenase (COX) Inhibitors

• Two COX isozymes: COX-1 and COX-2.• COX-1 – important in regulating mucin

secretion in stomach• COX-2 – promotes pain and inflammation and

fever (involved in prostaglandin synthesis).• Asprin (acetylsalicylate) non-specific COX

inhibitor. Acts by acetylating an essential serine residue in the active site.

• Because asprin inhibits COX-1, causes stomach upset and other side effects.

• New drugs (Vioxx and Celebrex) specifically inhibit COX-2

Page 7: Synthesis of Eicosanoids, Glycerolipids and Isoprenoids
Page 8: Synthesis of Eicosanoids, Glycerolipids and Isoprenoids

Glycerolipid Biosynthesis• Important for the synthesis of

membrane lipids and triacylglycerol

• Synthesis occurs primarily in ER • Phosphatidic acid (PA) is the

precursor for all other glycerolipids in eukaryotes

• PA is made either into diacylglycerol (DAG) or CDP-DAG

Page 9: Synthesis of Eicosanoids, Glycerolipids and Isoprenoids

Glycerolipid

Biosynthesis• Phosphatidic

acid is the precursor for all other glycerolipids

Page 10: Synthesis of Eicosanoids, Glycerolipids and Isoprenoids
Page 11: Synthesis of Eicosanoids, Glycerolipids and Isoprenoids

NH2

CH CH2C OH

O

OO P

O-

O

H2C

CH

CH2O

O

C

C

O

O

R1

R2

O

N

NH2

ON

O

OHOH

HH

HH

OP

O-

O

O P

O-

O

H2C

CH

CH2O

O

C

C

O

O

R1

R2

NH2

CH CH2C OH

O

HO

OO P

O-

O

H2C

CH

CH2O

O

C

C

O

O

R1

R2

OH

OH

OH OH

OH

H

H H

H

H

CMP CMP

CDP-DAG

phosphatidylserinephosphatidylinositol

SerineInositiol

Page 12: Synthesis of Eicosanoids, Glycerolipids and Isoprenoids

Isoprenoid Synthesis• Involves formation of

isopentenyl pyrophosphate (IPP) monmers.

• IPP is conjugated in a head to tail manner to generate polyprenyl compounds.

Page 13: Synthesis of Eicosanoids, Glycerolipids and Isoprenoids

•Formation of the isopentenyl pyrophosphate (IPP) via mevalonate pathway.•Primary pathway for isprenoid synthesis in animals and cytosolic isoprenoid synthesis in plants

Page 14: Synthesis of Eicosanoids, Glycerolipids and Isoprenoids

Mev

alon

ate

kina

se

Phos

phom

eval

onat

eki

nase pyrohosphomevalonate

decarboxylase

Formation of the isopentenyl pyrophosphate (IPP)

Page 15: Synthesis of Eicosanoids, Glycerolipids and Isoprenoids

Two Fates of HMG-CoA

Page 16: Synthesis of Eicosanoids, Glycerolipids and Isoprenoids

Bacteria and Plants Synthesize IPP via Non-

Mevalonate Pathway• In plants and most bacteria, IPP is

synthesized from the condensation of glyceraldehyde-3-phosphate (3 carbons) and pyruvate (3 carbons).

• Forms a 5 carbon intermediate through transketolase type reaction (transfer of 2 carbon aldehyde from pyruvate to G-3-P).

• Occurs in chloroplast of plants. Involved in synthesis of chlorophyll, carotenoids, Vitamins A, E and K.

Page 17: Synthesis of Eicosanoids, Glycerolipids and Isoprenoids

Very recent discovery (1996)

Pathway still not fully understood.

New pathway provides enzyme targets for new herbicidal and anti-microbial compounds

Page 18: Synthesis of Eicosanoids, Glycerolipids and Isoprenoids

Condensation of IPP into Polyprenyl

Compounds

Dimethylallylpryophosphate

IPP isomerase

Page 19: Synthesis of Eicosanoids, Glycerolipids and Isoprenoids

IPP Isomerase

prenyltransferase

prenyltransferase

Squalene synthase

Cholesterol

Synthesis from IPP

Page 20: Synthesis of Eicosanoids, Glycerolipids and Isoprenoids

Squalenemonooxygenase

2,3-oxidosqualenelanosterol cyclase

cholesterol20 steps

Page 21: Synthesis of Eicosanoids, Glycerolipids and Isoprenoids

Regulation of HMG-CoA Reductase

• As rate-limiting step, it is the principal site of regulation in cholesterol synthesis

• 1) Phosphorylation by cAMP-dependent kinases inactivates the reductase

• 2) Degradation of HMG-CoA reductase - half-life is 3 hrs and depends on cholesterol level

• 3) Gene expression (mRNA production) is controlled by cholesterol levels

Page 22: Synthesis of Eicosanoids, Glycerolipids and Isoprenoids

Inhibiting Cholesterol Synthesis

• HMG-CoA reductase is the key - the rate-limiting step in cholesterol biosynthesis

• Lovastatin (mevinolin) blocks HMG-CoA reductase and prevents synthesis of cholesterol

• Lovastatin is an (inactive) lactone• In the body, the lactone is

hydrolyzed to mevinolinic acid, a competitive (TSA!) inhibitor of the reductase, Ki = 0.6 nM!

Page 23: Synthesis of Eicosanoids, Glycerolipids and Isoprenoids